Novo-Nordisk A/S Newsroom

Market Chatter: Novo Nordisk's India Unit Reportedly Pushes for Earlier Wegovy Launch

MT Newswires02:48 ET

Sector Update: Health Care Stocks Decline Premarket Tuesday

MT Newswires09:18 ET

Weight Loss Drug Wars Heat Up: Amgen Challenges Eli Lilly, Novo's Dominance

Benzinga09:16 ET

Want To Bet On Ozempic, Wegovy Success? Defiance Introduces Leveraged ETF To Capture Novo Nordisk Momentum

Benzinga09:15 ET

Defiance ETFs Launched NVOX, The World's First Single-stock Leveraged ETF For The Pharmaceutical Stock Novo Nordisk

Benzinga06:03 ET

Concerned about falling behind eli lilly and co (LLY.US) and novo-nordisk a/s (NVO.US), the team in india urges to launch Wegovy in india as soon as possible.

Due to concerns about falling behind competitor eli lilly and co in the potentially huge market in india, the indian team of the danish pharmaceutical giant novo-nordisk a/s has been pushing for the earlier launch of its popular weight-loss drug Wegovy in india.

Zhitong Finance02:23 ET

Novo Nordisk (NVO) Among the Most Profitable Pharmaceutical Stocks Right Now

Yahoo Finance12:46 ET

10 Health Care Stocks With Whale Alerts In Today's Session

Benzinga12:35 ET

European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

MT Newswires11:16 ET

Weight Loss Drugs Like Wegovy, Zepbound Linked To Reduced Alcohol Use: Study

Benzinga11:01 ET

Novo Nordisk's Experimental Obesity Drug CagriSema Sales Forecast Overly Optimistic -- Market Talk

WSJDec 2 06:45 ET

Novo Nordisk's Sales Growth at Risk Over U.S. Price Erosion -- Market Talk

WSJDec 2 06:29 ET

Why Is Novo Nordisk A/S (NVO) Among Louis Navellier's Top Stock Picks Heading Into 2025?

Yahoo FinanceDec 1 14:42 ET

Novo Nordisk A/S (NVO): A Bull Case Theory

Yahoo FinanceNov 30 14:42 ET

What the Options Market Tells Us About Novo Nordisk

BenzingaNov 29 10:16 ET

Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum

BenzingaNov 29 08:42 ET

Aurisco Pharmaceutical (605116.SH): Currently, there is no collaboration with Novo-Nordisk A/S.

On November 28, Glonghui reported that aurisco pharmaceutical (605116.SH) stated on the investor interaction platform that the company is actively developing the market for the active pharmaceutical ingredient semaglutide, and currently has no collaboration with novo-nordisk a/s.

Gelonghui FinanceNov 28 04:39 ET

Sector Update: Health Care Stocks Advance Wednesday Afternoon

MT NewswiresNov 27 13:42 ET

LLY, NVO Stock Up as Biden Proposes Medicare Cover for Obesity Drugs

Zacks Nov 27 09:00 ET

Novo Nordisk, KKR Joint Acquisition of Sylvan Gets EU Greenlight

MT NewswiresNov 27 08:30 ET